e-Drug3D 720 |
NISOLDIPINE
|
cas 63675-72-9 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
ATC code |
PK parameters F 5 PERCENT Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET VOLTAGE-DEPENDENT CALCIUM CHANNEL |
DrugCentral Voltage-dependent L-type calcium channel subunit alpha-1C UNIPROT Q13936 CACNA1C Voltage-dependent L-type calcium channel subunit alpha-1D UNIPROT Q01668 CACNA1D |
Download SDF file | O5-methyl O3-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Formula: Calculated chemical properties: MW 388.41 NB_atoms 28 XLogP 3.20 PSA 99.394 NB_HD 1 NB_HA 7 fsp3 0.40 Lipinski(0=no;1=yes) 1 |
FDA NDA 020356 (label) INN (NISOLDIPINE) SULAR (AZURITY) APPROVAL= AP YEAR= 1995 NEWMOLECULARENTITY NDA 079051 (pdf not found) INN (NISOLDIPINE) NISOLDIPINE (MYLAN) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 091001 (pdf not found) INN (NISOLDIPINE) NISOLDIPINE (MYLAN) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 216606 (pdf not found) INN (NISOLDIPINE) NISOLDIPINE (AMTA) APPROVAL= AP YEAR= 2023 |
Other links: |